LIBMELDY - AN OVERVIEW

The FDA assessed the security and usefulness of atidarsagene autotemcel based on facts from 37 children who acquired atidarsagene autotemcel in two single-arm, open up-label scientific trials and in an expanded accessibility system.[7] Children who obtained cure with atidarsagene autotemcel were compared to untreated youngsters (purely natural hist